glp 1 and breast cancer survivor Sharing some research on GLP-1 medications (weight loss/ anti obesity medications) from the San Antonio Breast Cancer Symposium. We are beginning to see some early signals that they GLP-1s and Breast Cancer: Weight

Includes: Thermo to support calorie burn, energy, and sweat output

That timing helps align the therapy with the moments of highest metabolic demand

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis associated with GLP-1RA use compared to usual care

Interestingly, the benefit of liraglutide for tau phosphorylation in diabetic mice cannot be replicated by insulin treatment, suggesting that the unique neuroprotective effects of GLP-1RAs are medicated by pathways other than insulin signaling pathways [62]